You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 119 No. 6, JUNE 1967 TABLE OF CONTENTS
  Archives
  •  Online Features
  CASE REPORTS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (19)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Chronic Myelogenous Leukemia With Myelofibrosis

Four Years After Auto-immune Hemolytic Anemia

Seymour M. Cohen, MD

Arch Intern Med. 1967;119(6):620-625.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

ALTHOUGH in typical cases myelofibrosis with myeloid metaplasia is distinguishable from chronic myelogenous leukemia, there exist a number of cases in which the abnormalities are sufficiently similar to make differential diagnosis difficult.

The extreme case of myelofibrosis shows complete replacement of hematopoietic elements by connective tissue, either fibrous or osseous or both, and the classical chronic myelogenous leukemic marrow is hypercellular with a striking granulocytic preponderance, increased megakaryocytes, and normal nucleated or occasionally "megaloid" erythrocytes. However, the marrow pictures in the two conditions may be almost identical since myelofibrosis may be preceded or accompanied by hyperplasia of the marrow,1 and the marrow of undoubted cases of chronic myelogenous leukemia may show fibrosis in the later stages of the disease.2

These cases have raised the question of whether myelofibrosis with myeloid metaplasia and chronic myelogenous leukemia are different manifestations of the same fundamental disturbance.3 Newer techniques such as chromosome analysis and . . . [Full Text PDF of this Article]


Author Affiliations

New York

From the Department of Hematology, Mount Sinai Hospital, New York. Dr. Cohen was a fellow of the American Cancer Society; he is presently a captain in the US Air Force, Chanute Air Force Base, Ill.


Footnotes

Received for publication Dec 19, 1966; accepted March 3, 1967.

Reprint requests to USAF Hospital, Chanute Air Force Base, Ill 61866 (Dr. Cohen).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1967 American Medical Association. All Rights Reserved.